Get informed when a big investor buys or sells
+ FollowOvervalued by 33.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $6.68 Billion |
|---|---|
| Enterprise Value | $6.77 Billion |
| Annual dividend | $1.21 |
| Dividend yield | 2.28% |
| Earnings per Share | $1.13 |
| Beta | 0.26 |
| Outstanding Shares | 130,796,832 |
| P/E Ratio | 67.28 |
|---|---|
| PEG | -62.45 |
| Price to Sales | 1.46 |
| Price to Book Ratio | 3.93 |
| Enterprise Value to Revenue | 1.44 |
| Enterprise Value to EBIT | 8.25 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.16 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.01% |
|---|---|
| Total Invested | $10,370▼ 97.30% |
| Investors Holding | 30% |
Cochlear Limited is an Australian enterprise, established in Sydney in 1981, that specializes in advanced implantable hearing technology. This global company develops and distributes a range of auditory solutions for both pediatric and a...